Month: September 2021

TORONTO, Sept. 22, 2021 (GLOBE NEWSWIRE) — Revival Gold Inc. (TSXV: RVG, OTCQX: RVLGF) (“Revival Gold” or the “Company”), announces completion of the initial stage of the Company’s 2021 heap leach metallurgical test work program for the Beartrack-Arnett Gold Project (“Beartrack-Arnett”) located in Idaho, USA. The work is being performed by SGS Lakefield (“SGS”) under the direction of metallurgical staff from Revival Gold’s engineering consultant, Wood. Sample material, consisting of 1.94 tonnes of material from Beartrack and 0.80 tonnes of material from Arnett, was delivered to SGS in June 2021. The first stage of the test work program included head analysis, acid base accounting and bottle roll tests. The second stage of the program consists of column tests and will commence this month. The primary goal of the test work program...

VANCOUVER, British Columbia, Sept. 22, 2021 (GLOBE NEWSWIRE) — Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW) (OTCQB: AGNPF) (the “Company” or “Algernon”) a clinical stage pharmaceutical development company is pleased to announce that it has filed a pre-IND (Investigational New Drug) meeting request with the U.S. Food and Drug Administration (U.S. FDA) for its investigation of NP-120 (Ifenprodil) for the treatment of small cell lung cancer (SCLC).  This initiates formal communications with the U.S. FDA regarding development of the Company’s newly announced SCLC clinical research program and related license agreement with Dartmouth College. In the pre-IND meeting request application, the Company is confirming the direction it plans to take in the development of Ifenprodil as an adjunct to Topotecan for the treatment of...

VANCOUVER, British Columbia, Sept. 22, 2021 (GLOBE NEWSWIRE) — Benjamin Hill Mining Corp. (CSE: BNN) (OTCBB: BNNHF) (“BHM” or the “Company”) is pleased to announce their inaugural drill program for their never before drilled Sonora Gold property in the Caborca Gold belt of Sonora Mexico. The program consists of 80 strategic drill holes targeting the main mineralized structures in the Caracahui, Caracahui North, Sonora Copper, La Salada and Antenas exploration areas. The 80 sites were selected based on detailed mapping of mineralized structures and very encouraging surface sample assay results. Drill targets have been prioritized to assess areas where surface samples revealed the highest gold values and in locations that are accessible with minimal road building and ground disturbance (Figure 1). Benjamin Hill plans a phased approach...

YONKERS, N.Y., Sept. 22, 2021 (GLOBE NEWSWIRE) — ContraFect Corporation (Nasdaq: CFRX), a late clinical-stage biotechnology company focused on the discovery and development of direct lytic agents (DLAs), including lysins and amurin peptides, as new medical modalities for the treatment of life-threatening, antibiotic-resistant infections, announces today that Roger Pomerantz, M.D., President, Chief Executive Officer and Chairman of ContraFect, will participate in a fireside chat at the Cantor Global Virtual Healthcare Conference, which is being held from September 27 – 30, 2021. The fireside chat will be held on Wednesday, September 29 at 11:20 AM ET. A live webcast of the event will be available on the Investors & Media section of the Company’s website at www.contrafect.com. It will also be available as an archived webcast...

Industry leading nerve repair surgeons will share best practices and case studies during symposium session ALACHUA, Fla. and TAMPA, Fla., Sept. 22, 2021 (GLOBE NEWSWIRE) — Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for damage or discontinuity to peripheral nerves, announced that it will participate in the 76th Annual Meeting of the American Society for Surgery of the Hand (ASSH) being held in San Francisco from September 30-October 2, 2021. The meeting will offer both in-person and online attendance options with live-streaming of select sessions and on-demand access to pre-recorded scientific presentations. As an Elite level partner of ASSH, Axogen will host an industry forum breakfast symposium on Friday, October 1, 7:00-8:00 a.m. at the Moscone Center. Innovations in...

CHATHAM, N.J., Sept. 22, 2021 (GLOBE NEWSWIRE) — Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a clinical-stage biopharmaceutical company, announced today that Seth Lederman, M.D., President and Chief Executive Officer of Tonix, will present at the 2021 Cantor Virtual Global Healthcare Conference on September 28, 2021, at 2:00 p.m. ET. Investors interested in arranging a virtual meeting with the Company’s management during the conference should contact the Cantor conference coordinator. A webcast of the presentation will be available under the IR Events tab of the Investors section of the Tonix website at www.tonixpharma.com. A webcast replay will be accessible for 90 days following the event. About Tonix Pharmaceuticals Holding Corp. Tonix is a clinical-stage biopharmaceutical company focused on discovering,...